---
---

# 21 U.S.C., USLM ref /us/usc/t21/ch9

* Portions Copyright © 2016 the authors of the https://github.com/publicdocs project.
  Use of this file is subject to the NOTICE at [https://github.com/publicdocs/uscode/blob/master/NOTICE](https://github.com/publicdocs/uscode/blob/master/NOTICE)
* See the [Document Metadata](././../../../..//README.md) for more information.
  This file is generated from historical government data; content and/or formatting may be inaccurate and out-of-date and should not be used for official purposes.

----------
----------

[Previous](./../../../..//us/usc/t21/ch8/m__us_usc_t21_s221...237.md) | [Next](./../../../..//us/usc/t21/ch9/schI/m__us_usc_t21_ch9_schI.md) | [Root of Title](./../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fch9)

## CHAPTER 9—FEDERAL FOOD, DRUG, AND COSMETIC ACT

<table>

  <tr>

    <td> 

SUBCHAPTER I—SHORT TITLE  </td>

  </tr>

  <tr>

    <td> Sec.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs301" data-uslm-ref="/us/usc/t21/s301">301.</a>  </td>

    <td> Short title.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER II—DEFINITIONS  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs321" data-uslm-ref="/us/usc/t21/s321">321.</a>  </td>

    <td> Definitions; generally.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs321a" data-uslm-ref="/us/usc/t21/s321a">321a.</a>  </td>

    <td> “Butter” defined.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs321b" data-uslm-ref="/us/usc/t21/s321b">321b.</a>  </td>

    <td> “Package” defined.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs321c" data-uslm-ref="/us/usc/t21/s321c">321c.</a>  </td>

    <td> Nonfat dry milk; “milk” defined.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs321d" data-uslm-ref="/us/usc/t21/s321d">321d.</a>  </td>

    <td> Market names for catfish and ginseng.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER III—PROHIBITED ACTS AND PENALTIES  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs331" data-uslm-ref="/us/usc/t21/s331">331.</a>  </td>

    <td> Prohibited acts.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs332" data-uslm-ref="/us/usc/t21/s332">332.</a>  </td>

    <td> Injunction proceedings.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs333" data-uslm-ref="/us/usc/t21/s333">333.</a>  </td>

    <td> Penalties.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs333a" data-uslm-ref="/us/usc/t21/s333a">333a.</a>  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs334" data-uslm-ref="/us/usc/t21/s334">334.</a>  </td>

    <td> Seizure.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs335" data-uslm-ref="/us/usc/t21/s335">335.</a>  </td>

    <td> Hearing before report of criminal violation.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs335a" data-uslm-ref="/us/usc/t21/s335a">335a.</a>  </td>

    <td> Debarment, temporary denial of approval, and suspension.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs335b" data-uslm-ref="/us/usc/t21/s335b">335b.</a>  </td>

    <td> Civil penalties.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs335c" data-uslm-ref="/us/usc/t21/s335c">335c.</a>  </td>

    <td> Authority to withdraw approval of abbreviated drug applications.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs336" data-uslm-ref="/us/usc/t21/s336">336.</a>  </td>

    <td> Report of minor violations.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs337" data-uslm-ref="/us/usc/t21/s337">337.</a>  </td>

    <td> Proceedings in name of United States; provision as to subpoenas.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs337a" data-uslm-ref="/us/usc/t21/s337a">337a.</a>  </td>

    <td> Extraterritorial jurisdiction.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER IV—FOOD  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs341" data-uslm-ref="/us/usc/t21/s341">341.</a>  </td>

    <td> Definitions and standards for food.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs342" data-uslm-ref="/us/usc/t21/s342">342.</a>  </td>

    <td> Adulterated food.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs343" data-uslm-ref="/us/usc/t21/s343">343.</a>  </td>

    <td> Misbranded food.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs343%E2%80%931" data-uslm-ref="/us/usc/t21/s343–1">343–1.</a>  </td>

    <td> National uniform nutrition labeling.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs343%E2%80%932" data-uslm-ref="/us/usc/t21/s343–2">343–2.</a>  </td>

    <td> Dietary supplement labeling exemptions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs343%E2%80%933" data-uslm-ref="/us/usc/t21/s343–3">343–3.</a>  </td>

    <td> Disclosure.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs343a" data-uslm-ref="/us/usc/t21/s343a">343a.</a>  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs344" data-uslm-ref="/us/usc/t21/s344">344.</a>  </td>

    <td> Emergency permit control.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs345" data-uslm-ref="/us/usc/t21/s345">345.</a>  </td>

    <td> Regulations making exemptions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs346" data-uslm-ref="/us/usc/t21/s346">346.</a>  </td>

    <td> Tolerances for poisonous or deleterious substances in food; regulations.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs346a" data-uslm-ref="/us/usc/t21/s346a">346a.</a>  </td>

    <td> Tolerances and exemptions for pesticide chemical residues.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs346b" data-uslm-ref="/us/usc/t21/s346b">346b.</a>  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs347" data-uslm-ref="/us/usc/t21/s347">347.</a>  </td>

    <td> Intrastate sales of colored oleomargarine.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs347a" data-uslm-ref="/us/usc/t21/s347a">347a.</a>  </td>

    <td> Congressional declaration of policy regarding oleomargarine sales.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs347b" data-uslm-ref="/us/usc/t21/s347b">347b.</a>  </td>

    <td> Contravention of State laws.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs348" data-uslm-ref="/us/usc/t21/s348">348.</a>  </td>

    <td> Food additives.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs349" data-uslm-ref="/us/usc/t21/s349">349.</a>  </td>

    <td> Bottled drinking water standards; publication in Federal Register.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350" data-uslm-ref="/us/usc/t21/s350">350.</a>  </td>

    <td> Vitamins and minerals.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350a" data-uslm-ref="/us/usc/t21/s350a">350a.</a>  </td>

    <td> Infant formulas.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350b" data-uslm-ref="/us/usc/t21/s350b">350b.</a>  </td>

    <td> New dietary ingredients.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350c" data-uslm-ref="/us/usc/t21/s350c">350c.</a>  </td>

    <td> Maintenance and inspection of records.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350d" data-uslm-ref="/us/usc/t21/s350d">350d.</a>  </td>

    <td> Registration of food facilities.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350e" data-uslm-ref="/us/usc/t21/s350e">350e.</a>  </td>

    <td> Sanitary transportation practices.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350f" data-uslm-ref="/us/usc/t21/s350f">350f.</a>  </td>

    <td> Reportable food registry.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350g" data-uslm-ref="/us/usc/t21/s350g">350g.</a>  </td>

    <td> Hazard analysis and risk-based preventive controls.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350h" data-uslm-ref="/us/usc/t21/s350h">350h.</a>  </td>

    <td> Standards for produce safety.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350i" data-uslm-ref="/us/usc/t21/s350i">350i.</a>  </td>

    <td> Protection against intentional adulteration.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350j" data-uslm-ref="/us/usc/t21/s350j">350j.</a>  </td>

    <td> Targeting of inspection resources for domestic facilities, foreign facilities, and ports of entry; annual report.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350k" data-uslm-ref="/us/usc/t21/s350k">350k.</a>  </td>

    <td> Laboratory accreditation for analyses of foods.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350l" data-uslm-ref="/us/usc/t21/s350l">350l</a>.  </td>

    <td> Mandatory recall authority.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs350l" data-uslm-ref="/us/usc/t21/s350l">350l</a>–1.  </td>

    <td> Annual report to Congress.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER V—DRUGS AND DEVICES  </td>

  </tr>

  <tr>

    <td> 

Part A—Drugs and Devices  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs351" data-uslm-ref="/us/usc/t21/s351">351.</a>  </td>

    <td> Adulterated drugs and devices.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs352" data-uslm-ref="/us/usc/t21/s352">352.</a>  </td>

    <td> Misbranded drugs and devices.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs353" data-uslm-ref="/us/usc/t21/s353">353.</a>  </td>

    <td> Exemptions and consideration for certain drugs, devices, and biological products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs353a" data-uslm-ref="/us/usc/t21/s353a">353a.</a>  </td>

    <td> Pharmacy compounding.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs353a%E2%80%931" data-uslm-ref="/us/usc/t21/s353a–1">353a–1.</a>  </td>

    <td> Enhanced communication.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs353b" data-uslm-ref="/us/usc/t21/s353b">353b.</a>  </td>

    <td> Outsourcing facilities.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs353c" data-uslm-ref="/us/usc/t21/s353c">353c.</a>  </td>

    <td> Prereview of television advertisements.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs354" data-uslm-ref="/us/usc/t21/s354">354.</a>  </td>

    <td> Veterinary feed directive drugs.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs355" data-uslm-ref="/us/usc/t21/s355">355.</a>  </td>

    <td> New drugs.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs355%E2%80%931" data-uslm-ref="/us/usc/t21/s355–1">355–1.</a>  </td>

    <td> Risk evaluation and mitigation strategies.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs355a" data-uslm-ref="/us/usc/t21/s355a">355a.</a>  </td>

    <td> Pediatric studies of drugs.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs355b" data-uslm-ref="/us/usc/t21/s355b">355b.</a>  </td>

    <td> Adverse-event reporting.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs355c" data-uslm-ref="/us/usc/t21/s355c">355c.</a>  </td>

    <td> Research into pediatric uses for drugs and biological products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs355c%E2%80%931" data-uslm-ref="/us/usc/t21/s355c–1">355c–1.</a>  </td>

    <td> Report.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs355d" data-uslm-ref="/us/usc/t21/s355d">355d.</a>  </td>

    <td> Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs355e" data-uslm-ref="/us/usc/t21/s355e">355e.</a>  </td>

    <td> Pharmaceutical security.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs355f" data-uslm-ref="/us/usc/t21/s355f">355f.</a>  </td>

    <td> Extension of exclusivity period for new qualified infectious disease products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs356" data-uslm-ref="/us/usc/t21/s356">356.</a>  </td>

    <td> Expedited approval of drugs for serious or life-threatening diseases or conditions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs356%E2%80%931" data-uslm-ref="/us/usc/t21/s356–1">356–1.</a>  </td>

    <td> Accelerated approval of priority countermeasures.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs356a" data-uslm-ref="/us/usc/t21/s356a">356a.</a>  </td>

    <td> Manufacturing changes.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs356b" data-uslm-ref="/us/usc/t21/s356b">356b.</a>  </td>

    <td> Reports of postmarketing studies.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs356c" data-uslm-ref="/us/usc/t21/s356c">356c.</a>  </td>

    <td> Discontinuance or interruption in the production of life-saving drugs.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs356c%E2%80%931" data-uslm-ref="/us/usc/t21/s356c–1">356c–1.</a>  </td>

    <td> Annual reporting on drug shortages.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs356d" data-uslm-ref="/us/usc/t21/s356d">356d.</a>  </td>

    <td> Coordination; task force and strategic plan.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs356e" data-uslm-ref="/us/usc/t21/s356e">356e.</a>  </td>

    <td> Drug shortage list.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs356f" data-uslm-ref="/us/usc/t21/s356f">356f.</a>  </td>

    <td> Hospital repackaging of drugs in shortage.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs357" data-uslm-ref="/us/usc/t21/s357">357.</a>  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs358" data-uslm-ref="/us/usc/t21/s358">358.</a>  </td>

    <td> Authority to designate official names.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs359" data-uslm-ref="/us/usc/t21/s359">359.</a>  </td>

    <td> Nonapplicability of subchapter to cosmetics.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360" data-uslm-ref="/us/usc/t21/s360">360.</a>  </td>

    <td> Registration of producers of drugs or devices.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360a" data-uslm-ref="/us/usc/t21/s360a">360a.</a>  </td>

    <td> Clinical trial guidance for antibiotic drugs.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360a%E2%80%931" data-uslm-ref="/us/usc/t21/s360a–1">360a–1.</a>  </td>

    <td> Clinical trials.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360b" data-uslm-ref="/us/usc/t21/s360b">360b.</a>  </td>

    <td> New animal drugs.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360c" data-uslm-ref="/us/usc/t21/s360c">360c.</a>  </td>

    <td> Classification of devices intended for human use.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360c%E2%80%931" data-uslm-ref="/us/usc/t21/s360c–1">360c–1.</a>  </td>

    <td> Reporting.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360d" data-uslm-ref="/us/usc/t21/s360d">360d.</a>  </td>

    <td> Performance standards.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360e" data-uslm-ref="/us/usc/t21/s360e">360e.</a>  </td>

    <td> Premarket approval.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360e%E2%80%931" data-uslm-ref="/us/usc/t21/s360e–1">360e–1.</a>  </td>

    <td> Pediatric uses of devices.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360f" data-uslm-ref="/us/usc/t21/s360f">360f.</a>  </td>

    <td> Banned devices.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360g" data-uslm-ref="/us/usc/t21/s360g">360g.</a>  </td>

    <td> Judicial review.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360g%E2%80%931" data-uslm-ref="/us/usc/t21/s360g–1">360g–1.</a>  </td>

    <td> Agency documentation and review of significant decisions regarding devices.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360h" data-uslm-ref="/us/usc/t21/s360h">360h.</a>  </td>

    <td> Notification and other remedies.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360h%E2%80%931" data-uslm-ref="/us/usc/t21/s360h–1">360h–1.</a>  </td>

    <td> Program to improve the device recall system.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360i" data-uslm-ref="/us/usc/t21/s360i">360i.</a>  </td>

    <td> Records and reports on devices.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360j" data-uslm-ref="/us/usc/t21/s360j">360j.</a>  </td>

    <td> General provisions respecting control of devices intended for human use.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360k" data-uslm-ref="/us/usc/t21/s360k">360k.</a>  </td>

    <td> State and local requirements respecting devices.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360l" data-uslm-ref="/us/usc/t21/s360l">360l.</a>  </td>

    <td> Postmarket surveillance.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360m" data-uslm-ref="/us/usc/t21/s360m">360m.</a>  </td>

    <td> Accredited persons.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360n" data-uslm-ref="/us/usc/t21/s360n">360n.</a>  </td>

    <td> Priority review to encourage treatments for tropical diseases.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360n%E2%80%931" data-uslm-ref="/us/usc/t21/s360n–1">360n–1.</a>  </td>

    <td> Priority review for qualified infectious disease products.  </td>

  </tr>

  <tr>

    <td> 

Part B—Drugs for Rare Diseases or Conditions  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360aa" data-uslm-ref="/us/usc/t21/s360aa">360aa.</a>  </td>

    <td> Recommendations for investigations of drugs for rare diseases or conditions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bb" data-uslm-ref="/us/usc/t21/s360bb">360bb.</a>  </td>

    <td> Designation of drugs for rare diseases or conditions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360cc" data-uslm-ref="/us/usc/t21/s360cc">360cc.</a>  </td>

    <td> Protection for drugs for rare diseases or conditions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360dd" data-uslm-ref="/us/usc/t21/s360dd">360dd.</a>  </td>

    <td> Open protocols for investigations of drugs for rare diseases or conditions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360ee" data-uslm-ref="/us/usc/t21/s360ee">360ee.</a>  </td>

    <td> Grants and contracts for development of drugs for rare diseases and conditions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360ff" data-uslm-ref="/us/usc/t21/s360ff">360ff.</a>  </td>

    <td> Priority review to encourage treatments for rare pediatric diseases.  </td>

  </tr>

  <tr>

    <td> 

Part C—Electronic Product Radiation Control  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360hh" data-uslm-ref="/us/usc/t21/s360hh">360hh.</a>  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360ii" data-uslm-ref="/us/usc/t21/s360ii">360ii.</a>  </td>

    <td> Program of control.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360jj" data-uslm-ref="/us/usc/t21/s360jj">360jj.</a>  </td>

    <td> Studies by Secretary.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360kk" data-uslm-ref="/us/usc/t21/s360kk">360kk.</a>  </td>

    <td> Performance standards for electronic products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360ll" data-uslm-ref="/us/usc/t21/s360ll">360ll.</a>  </td>

    <td> Notification of defects in and repair or replacement of electronic products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360mm" data-uslm-ref="/us/usc/t21/s360mm">360mm.</a>  </td>

    <td> Imports.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360nn" data-uslm-ref="/us/usc/t21/s360nn">360nn.</a>  </td>

    <td> Inspection, records, and reports.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360oo" data-uslm-ref="/us/usc/t21/s360oo">360oo.</a>  </td>

    <td> Prohibited acts.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360pp" data-uslm-ref="/us/usc/t21/s360pp">360pp.</a>  </td>

    <td> Enforcement.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360qq" data-uslm-ref="/us/usc/t21/s360qq">360qq.</a>  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360rr" data-uslm-ref="/us/usc/t21/s360rr">360rr.</a>  </td>

    <td> Federal-State cooperation.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360ss" data-uslm-ref="/us/usc/t21/s360ss">360ss.</a>  </td>

    <td> State standards.  </td>

  </tr>

  <tr>

    <td> 

Part D—Dissemination of Treatment Information  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360aaa" data-uslm-ref="/us/usc/t21/s360aaa">360aaa</a> to <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360aaa%E2%80%936" data-uslm-ref="/us/usc/t21/s360aaa–6">360aaa–6.</a>  </td>

    <td> Omitted  </td>

  </tr>

  <tr>

    <td> 

Part E—General Provisions Relating to Drugs and Devices  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb" data-uslm-ref="/us/usc/t21/s360bbb">360bbb.</a>  </td>

    <td> Expanded access to unapproved therapies and diagnostics.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%931" data-uslm-ref="/us/usc/t21/s360bbb–1">360bbb–1.</a>  </td>

    <td> Dispute resolution.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%932" data-uslm-ref="/us/usc/t21/s360bbb–2">360bbb–2.</a>  </td>

    <td> Classification of products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%933" data-uslm-ref="/us/usc/t21/s360bbb–3">360bbb–3.</a>  </td>

    <td> Authorization for medical products for use in emergencies.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%933a" data-uslm-ref="/us/usc/t21/s360bbb–3a">360bbb–3a.</a>  </td>

    <td> Emergency use of medical products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%933b" data-uslm-ref="/us/usc/t21/s360bbb–3b">360bbb–3b.</a>  </td>

    <td> Products held for emergency use.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%934" data-uslm-ref="/us/usc/t21/s360bbb–4">360bbb–4.</a>  </td>

    <td> Countermeasure development, review, and technical assistance.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%935" data-uslm-ref="/us/usc/t21/s360bbb–5">360bbb–5.</a>  </td>

    <td> Critical Path Public-Private Partnerships.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%936" data-uslm-ref="/us/usc/t21/s360bbb–6">360bbb–6.</a>  </td>

    <td> Risk communication.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%937" data-uslm-ref="/us/usc/t21/s360bbb–7">360bbb–7.</a>  </td>

    <td> Notification.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%938" data-uslm-ref="/us/usc/t21/s360bbb–8">360bbb–8.</a>  </td>

    <td> Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%938a" data-uslm-ref="/us/usc/t21/s360bbb–8a">360bbb–8a.</a>  </td>

    <td> Optimizing global clinical trials.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%938b" data-uslm-ref="/us/usc/t21/s360bbb–8b">360bbb–8b.</a>  </td>

    <td> Use of clinical investigation data from outside the United States.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%938c" data-uslm-ref="/us/usc/t21/s360bbb–8c">360bbb–8c.</a>  </td>

    <td> Patient participation in medical product discussion.  </td>

  </tr>

  <tr>

    <td> 

Part F—New Animal Drugs for Minor Use and Minor Species  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360ccc" data-uslm-ref="/us/usc/t21/s360ccc">360ccc.</a>  </td>

    <td> Conditional approval of new animal drugs for minor use and minor species.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360ccc%E2%80%931" data-uslm-ref="/us/usc/t21/s360ccc–1">360ccc–1.</a>  </td>

    <td> Index of legally marketed unapproved new animal drugs for minor species.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360ccc%E2%80%932" data-uslm-ref="/us/usc/t21/s360ccc–2">360ccc–2.</a>  </td>

    <td> Designated new animal drugs for minor use or minor species.  </td>

  </tr>

  <tr>

    <td> 

Part G—Medical Gases  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360ddd" data-uslm-ref="/us/usc/t21/s360ddd">360ddd.</a>  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360ddd%E2%80%931" data-uslm-ref="/us/usc/t21/s360ddd–1">360ddd–1.</a>  </td>

    <td> Regulation of medical gases.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360ddd%E2%80%932" data-uslm-ref="/us/usc/t21/s360ddd–2">360ddd–2.</a>  </td>

    <td> Inapplicability of drug fees to designated medical gases.  </td>

  </tr>

  <tr>

    <td> 

Part H—Pharmaceutical Distribution Supply Chain  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360eee" data-uslm-ref="/us/usc/t21/s360eee">360eee.</a>  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360eee%E2%80%931" data-uslm-ref="/us/usc/t21/s360eee–1">360eee–1.</a>  </td>

    <td> Requirements.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360eee%E2%80%932" data-uslm-ref="/us/usc/t21/s360eee–2">360eee–2.</a>  </td>

    <td> National standards for prescription drug wholesale distributors.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360eee%E2%80%933" data-uslm-ref="/us/usc/t21/s360eee–3">360eee–3.</a>  </td>

    <td> National standards for third-party logistics providers.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360eee%E2%80%934" data-uslm-ref="/us/usc/t21/s360eee–4">360eee–4.</a>  </td>

    <td> Uniform national policy.  </td>

  </tr>

  <tr>

    <td> 

Part I—Nonprescription Sunscreen and Other Active Ingredients  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360fff" data-uslm-ref="/us/usc/t21/s360fff">360fff.</a>  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360fff%E2%80%931" data-uslm-ref="/us/usc/t21/s360fff–1">360fff–1.</a>  </td>

    <td> Submission of requests.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360fff%E2%80%932" data-uslm-ref="/us/usc/t21/s360fff–2">360fff–2.</a>  </td>

    <td> Eligibility determinations; data submission; filing.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360fff%E2%80%933" data-uslm-ref="/us/usc/t21/s360fff–3">360fff–3.</a>  </td>

    <td> GRASE determination.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360fff%E2%80%934" data-uslm-ref="/us/usc/t21/s360fff–4">360fff–4.</a>  </td>

    <td> Guidance; other provisions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360fff%E2%80%935" data-uslm-ref="/us/usc/t21/s360fff–5">360fff–5.</a>  </td>

    <td> Sunscreen monograph.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360fff%E2%80%936" data-uslm-ref="/us/usc/t21/s360fff–6">360fff–6.</a>  </td>

    <td> Non-sunscreen time and extent applications.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs360fff%E2%80%937" data-uslm-ref="/us/usc/t21/s360fff–7">360fff–7.</a>  </td>

    <td> Report.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER VI—COSMETICS  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs361" data-uslm-ref="/us/usc/t21/s361">361.</a>  </td>

    <td> Adulterated cosmetics.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs362" data-uslm-ref="/us/usc/t21/s362">362.</a>  </td>

    <td> Misbranded cosmetics.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs363" data-uslm-ref="/us/usc/t21/s363">363.</a>  </td>

    <td> Regulations making exemptions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs364" data-uslm-ref="/us/usc/t21/s364">364.</a>  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER VII—GENERAL AUTHORITY  </td>

  </tr>

  <tr>

    <td> 

Part A—General Administrative Provisions  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs371" data-uslm-ref="/us/usc/t21/s371">371.</a>  </td>

    <td> Regulations and hearings.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs372" data-uslm-ref="/us/usc/t21/s372">372.</a>  </td>

    <td> Examinations and investigations.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs372a" data-uslm-ref="/us/usc/t21/s372a">372a.</a>  </td>

    <td> Transferred.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs373" data-uslm-ref="/us/usc/t21/s373">373.</a>  </td>

    <td> Records.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs374" data-uslm-ref="/us/usc/t21/s374">374.</a>  </td>

    <td> Inspection.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs374a" data-uslm-ref="/us/usc/t21/s374a">374a.</a>  </td>

    <td> Inspections relating to food allergens.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs375" data-uslm-ref="/us/usc/t21/s375">375.</a>  </td>

    <td> Publicity.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs376" data-uslm-ref="/us/usc/t21/s376">376.</a>  </td>

    <td> Examination of sea food on request of packer; marking food with results; fees; penalties.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs377" data-uslm-ref="/us/usc/t21/s377">377.</a>  </td>

    <td> Revision of United States Pharmacopoeia; development of analysis and mechanical and physical tests.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs378" data-uslm-ref="/us/usc/t21/s378">378.</a>  </td>

    <td> Advertising of foods.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379" data-uslm-ref="/us/usc/t21/s379">379.</a>  </td>

    <td> Confidential information.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379a" data-uslm-ref="/us/usc/t21/s379a">379a.</a>  </td>

    <td> Presumption of existence of jurisdiction.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379b" data-uslm-ref="/us/usc/t21/s379b">379b.</a>  </td>

    <td> Consolidated administrative and laboratory facility.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379c" data-uslm-ref="/us/usc/t21/s379c">379c.</a>  </td>

    <td> Transferred.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379d" data-uslm-ref="/us/usc/t21/s379d">379d.</a>  </td>

    <td> Automation of Food and Drug Administration.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379d%E2%80%931" data-uslm-ref="/us/usc/t21/s379d–1">379d–1.</a>  </td>

    <td> Conflicts of interest.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379d%E2%80%932" data-uslm-ref="/us/usc/t21/s379d–2">379d–2.</a>  </td>

    <td> Policy on the review and clearance of scientific articles published by FDA employees.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379d%E2%80%933" data-uslm-ref="/us/usc/t21/s379d–3">379d–3.</a>  </td>

    <td> Streamlined hiring authority.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379d%E2%80%934" data-uslm-ref="/us/usc/t21/s379d–4">379d–4.</a>  </td>

    <td> Reporting requirements.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379d%E2%80%935" data-uslm-ref="/us/usc/t21/s379d–5">379d–5.</a>  </td>

    <td> Guidance document regarding product promotion using the Internet.  </td>

  </tr>

  <tr>

    <td> 

Part B—Colors  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379e" data-uslm-ref="/us/usc/t21/s379e">379e.</a>  </td>

    <td> Listing and certification of color additives for foods, drugs, devices, and cosmetics.  </td>

  </tr>

  <tr>

    <td> 

Part C—Fees  </td>

  </tr>

  <tr>

    <td> 

subpart 1—freedom of information fees  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379f" data-uslm-ref="/us/usc/t21/s379f">379f.</a>  </td>

    <td> Recovery and retention of fees for freedom of information requests.  </td>

  </tr>

  <tr>

    <td> 

subpart 2—fees relating to drugs  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379g" data-uslm-ref="/us/usc/t21/s379g">379g.</a>  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379h" data-uslm-ref="/us/usc/t21/s379h">379h.</a>  </td>

    <td> Authority to assess and use drug fees.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379h%E2%80%931" data-uslm-ref="/us/usc/t21/s379h–1">379h–1.</a>  </td>

    <td> Fees relating to advisory review of prescription-drug television advertising.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379h%E2%80%932" data-uslm-ref="/us/usc/t21/s379h–2">379h–2.</a>  </td>

    <td> Reauthorization; reporting requirements.  </td>

  </tr>

  <tr>

    <td> 

subpart 3—fees relating to devices  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379i" data-uslm-ref="/us/usc/t21/s379i">379i.</a>  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j" data-uslm-ref="/us/usc/t21/s379j">379j.</a>  </td>

    <td> Authority to assess and use device fees.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%931" data-uslm-ref="/us/usc/t21/s379j–1">379j–1.</a>  </td>

    <td> Reauthorization; reporting requirements.  </td>

  </tr>

  <tr>

    <td> 

subpart 4—fees relating to animal drugs  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9311" data-uslm-ref="/us/usc/t21/s379j–11">379j–11.</a>  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9312" data-uslm-ref="/us/usc/t21/s379j–12">379j–12.</a>  </td>

    <td> Authority to assess and use animal drug fees.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9313" data-uslm-ref="/us/usc/t21/s379j–13">379j–13.</a>  </td>

    <td> Reauthorization; reporting requirements.  </td>

  </tr>

  <tr>

    <td> 

subpart 5—fees relating to generic new animal drugs  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9321" data-uslm-ref="/us/usc/t21/s379j–21">379j–21.</a>  </td>

    <td> Authority to assess and use generic new animal drug fees.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9322" data-uslm-ref="/us/usc/t21/s379j–22">379j–22.</a>  </td>

    <td> Reauthorization; reporting requirements.  </td>

  </tr>

  <tr>

    <td> 

subpart 6—fees related to food  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9331" data-uslm-ref="/us/usc/t21/s379j–31">379j–31.</a>  </td>

    <td> Authority to collect and use fees.  </td>

  </tr>

  <tr>

    <td> 

subpart 7—fees relating to generic drugs  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9341" data-uslm-ref="/us/usc/t21/s379j–41">379j–41.</a>  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9342" data-uslm-ref="/us/usc/t21/s379j–42">379j–42.</a>  </td>

    <td> Authority to assess and use human generic drug fees.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9343" data-uslm-ref="/us/usc/t21/s379j–43">379j–43.</a>  </td>

    <td> Reauthorization; reporting requirements.  </td>

  </tr>

  <tr>

    <td> 

subpart 8—fees relating to biosimilar biological products  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9351" data-uslm-ref="/us/usc/t21/s379j–51">379j–51.</a>  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9352" data-uslm-ref="/us/usc/t21/s379j–52">379j–52.</a>  </td>

    <td> Authority to assess and use biosimilar biological product fees.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9353" data-uslm-ref="/us/usc/t21/s379j–53">379j–53.</a>  </td>

    <td> Reauthorization; reporting requirements.  </td>

  </tr>

  <tr>

    <td> 

subpart 9—fees relating to outsourcing facilities  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9361" data-uslm-ref="/us/usc/t21/s379j–61">379j–61.</a>  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379j%E2%80%9362" data-uslm-ref="/us/usc/t21/s379j–62">379j–62.</a>  </td>

    <td> Authority to assess and use outsourcing facility fees.  </td>

  </tr>

  <tr>

    <td> 

Part D—Information and Education  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379k" data-uslm-ref="/us/usc/t21/s379k">379k.</a>  </td>

    <td> Information system.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379k%E2%80%931" data-uslm-ref="/us/usc/t21/s379k–1">379k–1.</a>  </td>

    <td> Electronic format for submissions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379l" data-uslm-ref="/us/usc/t21/s379l">379l</a>.  </td>

    <td> Education.  </td>

  </tr>

  <tr>

    <td> 

Part E—Environmental Impact Review  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379o" data-uslm-ref="/us/usc/t21/s379o">379o</a>.  </td>

    <td> Environmental impact.  </td>

  </tr>

  <tr>

    <td> 

Part F—National Uniformity for Nonprescription Drugs and Preemption for Labeling or Packaging of Cosmetics  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379r" data-uslm-ref="/us/usc/t21/s379r">379r.</a>  </td>

    <td> National uniformity for nonprescription drugs.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379s" data-uslm-ref="/us/usc/t21/s379s">379s.</a>  </td>

    <td> Preemption for labeling or packaging of cosmetics.  </td>

  </tr>

  <tr>

    <td> 

Part G—Safety Reports  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379v" data-uslm-ref="/us/usc/t21/s379v">379v.</a>  </td>

    <td> Safety report disclaimers.  </td>

  </tr>

  <tr>

    <td> 

Part H—Serious Adverse Event Reports  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379aa" data-uslm-ref="/us/usc/t21/s379aa">379aa.</a>  </td>

    <td> Serious adverse event reporting for nonprescription drugs.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379aa%E2%80%931" data-uslm-ref="/us/usc/t21/s379aa–1">379aa–1.</a>  </td>

    <td> Serious adverse event reporting for dietary supplements.  </td>

  </tr>

  <tr>

    <td> 

Part I—Reagan-Udall Foundation for the Food and Drug Administration  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379dd" data-uslm-ref="/us/usc/t21/s379dd">379dd.</a>  </td>

    <td> Establishment and functions of the Foundation.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379dd%E2%80%931" data-uslm-ref="/us/usc/t21/s379dd–1">379dd–1.</a>  </td>

    <td> Location of Foundation.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs379dd%E2%80%932" data-uslm-ref="/us/usc/t21/s379dd–2">379dd–2.</a>  </td>

    <td> Activities of the Food and Drug Administration.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER VIII—IMPORTS AND EXPORTS  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs381" data-uslm-ref="/us/usc/t21/s381">381.</a>  </td>

    <td> Imports and exports.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs382" data-uslm-ref="/us/usc/t21/s382">382.</a>  </td>

    <td> Exports of certain unapproved products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs383" data-uslm-ref="/us/usc/t21/s383">383.</a>  </td>

    <td> Office of International Relations.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs384" data-uslm-ref="/us/usc/t21/s384">384.</a>  </td>

    <td> Importation of prescription drugs.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs384a" data-uslm-ref="/us/usc/t21/s384a">384a.</a>  </td>

    <td> Foreign supplier verification program.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs384b" data-uslm-ref="/us/usc/t21/s384b">384b.</a>  </td>

    <td> Voluntary qualified importer program.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs384c" data-uslm-ref="/us/usc/t21/s384c">384c.</a>  </td>

    <td> Inspection of foreign food facilities.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs384d" data-uslm-ref="/us/usc/t21/s384d">384d.</a>  </td>

    <td> Accreditation of third-party auditors.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs384e" data-uslm-ref="/us/usc/t21/s384e">384e.</a>  </td>

    <td> Recognition of foreign government inspections.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER IX—TOBACCO PRODUCTS  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387" data-uslm-ref="/us/usc/t21/s387">387.</a>  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387a" data-uslm-ref="/us/usc/t21/s387a">387a.</a>  </td>

    <td> FDA authority over tobacco products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387a%E2%80%931" data-uslm-ref="/us/usc/t21/s387a–1">387a–1.</a>  </td>

    <td> Final rule.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387b" data-uslm-ref="/us/usc/t21/s387b">387b.</a>  </td>

    <td> Adulterated tobacco products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387c" data-uslm-ref="/us/usc/t21/s387c">387c.</a>  </td>

    <td> Misbranded tobacco products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387d" data-uslm-ref="/us/usc/t21/s387d">387d.</a>  </td>

    <td> Submission of health information to the Secretary.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387e" data-uslm-ref="/us/usc/t21/s387e">387e.</a>  </td>

    <td> Annual registration.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387f" data-uslm-ref="/us/usc/t21/s387f">387f.</a>  </td>

    <td> General provisions respecting control of tobacco products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387f%E2%80%931" data-uslm-ref="/us/usc/t21/s387f–1">387f–1.</a>  </td>

    <td> Enforcement action plan for advertising and promotion restrictions.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387g" data-uslm-ref="/us/usc/t21/s387g">387g.</a>  </td>

    <td> Tobacco product standards.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387h" data-uslm-ref="/us/usc/t21/s387h">387h.</a>  </td>

    <td> Notification and other remedies.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387i" data-uslm-ref="/us/usc/t21/s387i">387i.</a>  </td>

    <td> Records and reports on tobacco products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387j" data-uslm-ref="/us/usc/t21/s387j">387j.</a>  </td>

    <td> Application for review of certain tobacco products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387k" data-uslm-ref="/us/usc/t21/s387k">387k.</a>  </td>

    <td> Modified risk tobacco products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387l" data-uslm-ref="/us/usc/t21/s387l">387l</a>.  </td>

    <td> Judicial review.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387m" data-uslm-ref="/us/usc/t21/s387m">387m.</a>  </td>

    <td> Equal treatment of retail outlets.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387n" data-uslm-ref="/us/usc/t21/s387n">387n.</a>  </td>

    <td> Jurisdiction of and coordination with the Federal Trade Commission.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387o" data-uslm-ref="/us/usc/t21/s387o">387o</a>.  </td>

    <td> Regulation requirement.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387p" data-uslm-ref="/us/usc/t21/s387p">387p.</a>  </td>

    <td> Preservation of State and local authority.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387q" data-uslm-ref="/us/usc/t21/s387q">387q.</a>  </td>

    <td> Tobacco Products Scientific Advisory Committee.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387r" data-uslm-ref="/us/usc/t21/s387r">387r.</a>  </td>

    <td> Drug products used to treat tobacco dependence.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387s" data-uslm-ref="/us/usc/t21/s387s">387s.</a>  </td>

    <td> User fees.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387t" data-uslm-ref="/us/usc/t21/s387t">387t.</a>  </td>

    <td> Labeling, recordkeeping, records inspection.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs387u" data-uslm-ref="/us/usc/t21/s387u">387u.</a>  </td>

    <td> Studies of progress and effectiveness.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER X—MISCELLANEOUS  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs391" data-uslm-ref="/us/usc/t21/s391">391.</a>  </td>

    <td> Separability clause.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs392" data-uslm-ref="/us/usc/t21/s392">392.</a>  </td>

    <td> Exemption of meats and meat food products.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs393" data-uslm-ref="/us/usc/t21/s393">393.</a>  </td>

    <td> Food and Drug Administration.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs393a" data-uslm-ref="/us/usc/t21/s393a">393a.</a>  </td>

    <td> Office of Pediatric Therapeutics.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs394" data-uslm-ref="/us/usc/t21/s394">394.</a>  </td>

    <td> Scientific review groups.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs395" data-uslm-ref="/us/usc/t21/s395">395.</a>  </td>

    <td> Loan repayment program.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs396" data-uslm-ref="/us/usc/t21/s396">396.</a>  </td>

    <td> Practice of medicine.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs397" data-uslm-ref="/us/usc/t21/s397">397.</a>  </td>

    <td> Contracts for expert review.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs398" data-uslm-ref="/us/usc/t21/s398">398.</a>  </td>

    <td> Notices to States regarding imported food.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs399" data-uslm-ref="/us/usc/t21/s399">399.</a>  </td>

    <td> Grants to enhance food safety.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs399a" data-uslm-ref="/us/usc/t21/s399a">399a.</a>  </td>

    <td> Office of the Chief Scientist.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs399b" data-uslm-ref="/us/usc/t21/s399b">399b.</a>  </td>

    <td> Office of Women’s Health.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs399c" data-uslm-ref="/us/usc/t21/s399c">399c.</a>  </td>

    <td> Improving the training of State, local, territorial, and tribal food safety officials.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs399d" data-uslm-ref="/us/usc/t21/s399d">399d.</a>  </td>

    <td> Employee protections.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs399e" data-uslm-ref="/us/usc/t21/s399e">399e.</a>  </td>

    <td> Nanotechnology.  </td>

  </tr>

  <tr>

    <td> <a href="https://publicdocs.github.io/go/links?ns=uslm&amp;ref=%2Fus%2Fusc%2Ft21%2Fs399f" data-uslm-ref="/us/usc/t21/s399f">399f.</a>  </td>

    <td> Ensuring adequate information regarding pharmaceuticals for all populations, particularly underrepresented subpopulations, including racial subgroups.  </td>

  </tr>

</table>

----------

[Previous](./../../../..//us/usc/t21/ch8/m__us_usc_t21_s221...237.md) | [Next](./../../../..//us/usc/t21/ch9/schI/m__us_usc_t21_ch9_schI.md) | [Root of Title](./../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fch9)

----------
----------



